Consonance Capital Management LP Vericel Corp Transaction History
Consonance Capital Management LP
- $7.28 Million
- Q3 2022
Shares
11 transactions
Others Institutions Holding VCEL
# of Institutions
275Shares Held
48.8MCall Options Held
120KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$447 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$212 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$193 Million0.0% of portfolio
-
State Street Corp Boston, MA2.43MShares$135 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$131 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.62B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...